John J. Alam - Sep 15, 2023 Form 4 Insider Report for CervoMed Inc. (DFFN)

Role: CEO & President, Director, 10%+ Owner
Signature: /s/ William R. Elder, attorney-in-fact for the Reporting Person
Stock symbol: DFFN
Transactions as of: Sep 15, 2023
Transactions value $: $0
Form type: 4
Date filed: 9/15/2023, 06:54 PM
Previous filing: Aug 23, 2023
Next filing: Nov 9, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	DFFN	Stock Option (Right to Buy)	Award	$0	+35.5K		$0.00	35.5K	Sep 15, 2023	Common Stock	35.5K	$5.33	Direct	F1
transaction	DFFN	Stock Option (Right to Buy)	Award	$0	+6.45K		$0.00	6.45K	Sep 15, 2023	Common Stock	6.45K	$5.33	By Spouse	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares of common stock underlying the award will vest in 36 equal (or as near equal as possible) monthly installments on the last calendar day of each month over a 36-month period commencing September 30, 2023.
F2	Consists of an option to purchase shares of common stock granted to Sylvie Gregoire, Pharm.D., the Reporting Person's spouse and the Chair of the Board of the Issuer. The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

Content

The shares of common stock underlying the award will vest in 36 equal (or as near equal as possible) monthly installments on the last calendar day of each month over a 36-month period commencing September 30, 2023.

Consists of an option to purchase shares of common stock granted to Sylvie Gregoire, Pharm.D., the Reporting Person's spouse and the Chair of the Board of the Issuer. The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.